Annals of Oncology, 0923-7534

Journal

  1. 2019
  2. Lindsay, C. R., Blackhall, F. H., Carmel, A., Gazzaniga, P., Groen, H. J. M., Krebs, M. G., ... Michiels, S. (2019). EPAC-Lung: Pooled analysis of circulating tumor cells in advanced non-small cell lung cancer. Annals of Oncology, 30.
  3. Witlox, W. J. A., Ramaekers, B., Groen, H. J. M., Dingemans, A-M. C., Praag, J., Belderbos, J., ... De Ruysscher, D. (2019). The effect of prophylactic cranial irradiation (PCI) for young stage III NSCLC patients: Subgroup analyses of the NVALT-11/DLCRG-02 study. Annals of Oncology, 30, 33-+.
  4. 2018
  5. van Zeijl, M. C. T., Wouters, M. W. J. M., van den Eertwegh, A. J., Aarts, M. J., van Akkooi, A. C. J., van den Berkmortel, F. W. P. J., ... Haanen, J. B. A. G. (2018). Outcomes of anti-PD1 antibodies for advanced melanoma in real-world population. Annals of Oncology, 29(Suppl.8), viii455. [1276P]. https://doi.org/10.1093/annonc/mdy289.032
  6. van Veggel, B., van der Wekken, A., Hashemi, S., Cornelissen, R., Monkhorst, K., Heideman, D., ... De Langen, J. (2018). Osimertinib treatment for patients with EGFR exon 20 insertion positive non-small cell lung cancer. Annals of Oncology, 29(Suppl.8), viii524-viii525. https://doi.org/10.1093/annonc/mdy292.072
  7. ESMO Guidelines Committee and EURACAN, Casali, P. G., Abecassis, N., Bauer, S., Biagini, R., Bielack, S., ... Van der Graaf, W. (2018). Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 29(Suppl.4), 51-67. https://doi.org/10.1093/annonc/mdy096
  8. Oosting, S., Desideri, I., Staelens, D., Caballero, C., Tribius, S., Simon, C., ... Luciani, A. (2018). Treatment patterns in elderly patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results from an EORTC led survey. Annals of Oncology, 29(Suppl_8), 393-393.
  9. Honecker, F., Aparicio, J., Berney, D., Beyer, J., Bokemeyer, C., Cathomas, R., ... Horwich, A. (2018). ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up. Annals of Oncology, 29(8), 1658-1686. https://doi.org/10.1093/annonc/mdy217
  10. Wang, H., Agulnik, J., Kasymjanova, G., Wang, A., Jiménez, P., Cohen, V., ... Spatz, A. (2018). Cytology cell blocks are suitable for immunohistochemical testing for PD-L1 in lung cancer. Annals of Oncology, 29(6), 1417-1422. https://doi.org/10.1093/annonc/mdy126
  11. Cardoso, F., Bartlett, J. M. S., Slaets, L., van Deurzen, C. H. M., van Leeuwen-Stok, E., Porter, P., ... Giordano, S. H. (2018). Characterization of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Annals of Oncology, 29(2), 405-417. https://doi.org/10.1093/annonc/mdx651
  12. 2017
  13. van der Velden, D. L., van Herpen, C. M. L., van Laarhoven, H. W. M., Smit, E. F., Groen, H. J. M., Willems, S. M., ... Voest, E. E. (2017). Molecular Tumor Boards: Current practice and future needs. Annals of Oncology, 28(12), 3070-3075. https://doi.org/10.1093/annonc/mdx528
  14. Cherny, N. I., Dafni, U., Bogaerts, J., Latino, N. J., Pentheroudakis, G., Douillard, J. -Y., ... de Vries, E. G. E. (2017). ESMO-Magnitude of Clinical Benefit Scale version 1.1. Annals of Oncology, 28(10), 2340-2366. https://doi.org/10.1093/annonc/mdx310
  15. Valent, P., Akin, C., Hartmann, K., George, T. I., Sotlar, K., Peter, B., ... Gotlib, J. (2017). Midostaurin: A magic bullet that blocks mast cell expansion and activation. Annals of Oncology, 28(10), 2367-2376. https://doi.org/10.1093/annonc/mdx290
  16. Derks, J., Leblay, N., van Suylen, R. J., Thunnissen, E., den Bakker, M. A., Groen, H. J. M., ... Dingemans, A-M. (2017). Genomic subtypes of pulmonary large cell neuroendocrine carcinoma (LCNEC) may predict chemotherapy outcome. Annals of Oncology, 28.
  17. Cherny, N. I., Dafni, U., Bogaerts, J., Pentheroudakis, G., Tabernero, J., Zielinski, C., ... de Vries, E. G. E. (2017). Reply to the letter to the editor 'Addressing the quality of the ESMO-MCBS' by Del Paggio. Annals of Oncology, 28(8), 2031-2032. https://doi.org/10.1093/annonc/mdx200
  18. Smit, E., Soria, J-C., Janjigian, Y. Y., Groen, H. J. M., Pao, W., Calvo, E., ... Horn, L. (2017). Afatinib (A) plus cetuximab (C) in the treatment of patients (pts) with NSCLC: The story so far. Annals of Oncology, 28.
Previous 1 2 3 4 Next

ID: 13479495